Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

Share Price is delayed by 15 minutes
Get Live Data
2,885.00    70.00 (2.49%)
Bid:
2,845.00
Ask:
2,865.00
Spread: 20.00 (0.703%)
Market Cap: £2.26b
HILS Live PriceLast checked at - London Stock Exchange

Intraday Hill & Smith Share Chart

Director/PDMR Shareholding

14 Oct 2025 13:08

RNS Number : 3359D
Hill & Smith PLC
14 October 2025
Β 

14 October 2025

HILL & SMITH PLC

("Hill & Smith" or the "Company")

Grant of Nil-Cost Options

On 13 October 2025 (the "Grant Date") the Company granted awards in the form nil-cost options over a total of 67,211 ordinary shares in the Company to Chris McLeish, the Company's Chief Financial Officer, comprising:

Β 

(a) five standalone awards over the number of shares specified in the table below, which reflect three deferred bonus and two long-term incentive awards forfeited by Chris McLeish as a result of him ceasing to be an employee of his previous employer, Ibstock plc, in order to join Hill & Smith, as agreed as part of his recruitment package (the "Buyout Awards")

Β 

Β 

Number of Hill & Smith shares

Exercisable from

2023 Deferred Bonus Buy-Out Award

5,088

16 March 2026

2023 LTIP Buy-Out Award

19,789

03 April 2028

2024 Deferred Bonus Buy-Out Award

1,782

22 March 2027

2024 LTIP Buy-Out Award

24,082

03 April 2029

2025 Deferred Bonus Buy-Out Award

3,552

20 March 2028

Β 

(b) an award under the Hill & Smith 2023 Long Term Incentive Plan (the "LTIP") over 12,918 Shares (the "2025 LTIP Award").

Β 

Buyout Awards

Β 

The buy-out arrangements were structured in accordance with the principles set out in the Company's approved Remuneration Policy, in particular that they should be made on a comparable basis to the remuneration arrangements forfeited. The structure of the awards mirrors as far as is reasonably practicable what was forfeited on leaving Ibstock, and the conversion into Hill & Smith shares on joining provides alignment with Hill & Smith shareholders. The LTIP Buyout Awards are, therefore, subject to the same performance conditions and post-vesting holding period as the forfeited Ibstock LTIP awards. Further details will be contained within the 2025 Directors' Remuneration Report.

Β 

The Buyout Awards will become exercisable on the same dates as the awards they replace (in the case of the LTIP Buyout Awards, provided the Company's Remuneration Committee can assess the extent to which the performance conditions are met).

Β 

The number of ordinary shares over which the Buyout Awards were granted was based on the average mid-market closing share price of Hill & Smith and Ibstock plc for the thirty business days prior to the Grant Date, as derived from the London Stock Exchange daily official list.

The exercise of the Buyout Awards will not be satisfied with an issue of shares or a transfer of treasury shares.

2025 LTIP Award

The 2025 LTIP Award reflects the 2025 award granted under the LTIP to the Company's CEO (and certain other employees) on 1 April 2025. However, recognising that a proportion of the performance period has elapsed, the award has been granted with a value representing 60% of Chris McLeish's base salary as at the Grant Date (rather than the maximum annual LTIP award value of 150% permitted for the CFO by the Company's Directors' Remuneration Policy).

The number of shares over which the 2025 LTIP Award was granted was calculated based on a share price of Β£20.90 being the closing mid-market share price on the day immediately preceding the Grant Date.

As per the CEO's 2025 award, the 2025 LTIP Award will vest based on the achievement of performance conditions based on relative Total Shareholder Return (40%), Underlying EPS Growth (50%) and the Company's reduction in greenhouse gas emissions (10%) over a 3-year performance period. The detailed performance conditions will be provided in the 2025 Directors' Remuneration Report. The 2025 LTIP Award will (subject to the achievement of the performance conditions) vest following the end of the performance period, and may not ordinarily be exercised until the end of a further two-year holding period.

General

As a result of these transactions Chris McLeish holds options over 67,211 ordinary shares in the Company.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.

Enquiries:

Karen Atterbury

Company Secretary

0121 704 7430

Β 

Buyout Awards

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Chris McLeish

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Nil-cost options over ordinary shares of Β£0.25 each

Identification code of the Financial Instrument

GB0004270301

(b)

Nature of the transaction

Grant of nil-cost options to acquire ordinary shares in the Company in compensation for awards forfeited on leaving former employer

(c)

Price(s) and volume(s)

Price(s)

Volume

Nil

19,789

Nil

24,082

Nil

5,088

Nil

1,782

Nil

3,552

(d)

Aggregated information:

- Aggregated volume

Β 

- Price

Β 

54,293

Nil

(e)

Date of the transaction

13 October 2025

(f)

Place of the transaction

Outside a trading venue

Β 

Β 

2025 LTIP Award

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Chris McLeish

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Nil-cost option over ordinary shares of Β£0.25 each

Identification code of the Financial Instrument

GB0004270301

(b)

Nature of the transaction

Grant of 2025 LTIP award (in the form of a nil-cost option to acquire ordinary shares in the Company)

(c)

Price(s) and volume(s)

Price(s)

Volume

Nil

12,918

(d)

Aggregated information:

- Aggregated volume

Β 

- Price

Β 

12,918

Nil

(e)

Date of the transaction

13 October 2025

(f)

Place of the transaction

Outside a trading venue

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHPKQBKBBDDAKD
Date   Source Headline
4th Jul 201410:51 amRNSTotal Voting Rights
11th Jun 20142:24 pmRNSNotice of Results
29th May 20142:54 pmRNSAdditional Listing
22nd May 201412:14 pmRNSDirector/PDMR Shareholding
21st May 20144:37 pmRNSAward of options
14th May 20144:11 pmRNSResult of AGM
14th May 20147:00 amRNSInterim Management Statement
17th Apr 201411:15 amRNSDirector/PDMR Shareholding
10th Apr 20144:33 pmRNSHolding(s) in Company
9th Apr 20144:11 pmRNSDirector/PDMR Shareholding
3rd Apr 20144:26 pmRNS2013 Annual Report & Notice of AGM
3rd Apr 20141:08 pmRNSTotal Voting Rights
28th Mar 201411:29 amRNSDirector/PDMR Shareholding
19th Mar 20144:09 pmRNSDirector/PDMR Shareholding
19th Mar 201410:39 amRNSDirector/PDMR Shareholding
11th Mar 20147:00 amRNSFinal Results
3rd Mar 20141:57 pmRNSTotal Voting Rights
3rd Feb 201410:56 amRNSTotal Voting Rights
28th Jan 20147:00 amRNSNotice of Results
17th Jan 201410:48 amRNSBlocklisting Interim Review
13th Jan 20145:22 pmRNSHolding(s) in Company
8th Jan 20147:00 amRNSTotal Voting Rights
6th Jan 20143:39 pmRNSHolding(s) in Company
19th Dec 20137:00 amRNSTelford Closure
14th Nov 20137:00 amRNSInterim Management Statement
1st Nov 20137:00 amRNSTotal Voting Rights
27th Sep 20138:56 amRNSNotice of IMS
16th Aug 20138:43 amRNSHolding(s) in Company
6th Aug 20137:00 amRNSHalf Yearly Report
17th Jul 201310:58 amRNSBlocklisting Interim Review
2nd Jul 20133:52 pmRNSTotal Voting Rights
13th Jun 20132:15 pmRNSNotice of Results
3rd Jun 20137:00 amRNSTotal Voting Rights
15th May 20133:15 pmRNSResult of AGM
15th May 20137:00 amRNSInterim Management Statement
11th Apr 20134:23 pmRNSAnnual Report & Accounts and AGM Notice
11th Apr 20133:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20137:00 amRNSTotal Voting Rights
19th Mar 20133:46 pmRNSDirector/PDMR Shareholding
15th Mar 201310:18 amRNSHolding(s) in Company Replacement
15th Mar 20138:11 amRNSHolding(s) in Company
14th Mar 201312:28 pmRNSHolding(s) in Company
13th Mar 20134:08 pmRNSDirector/PDMR Shareholding
12th Mar 20137:00 amRNSFinal Results
1st Mar 201311:07 amRNSTotal Voting Rights
1st Feb 20137:00 amRNSTotal Voting Rights
21st Jan 20137:00 amRNSAdditional Listing
17th Jan 201312:55 pmRNSBlocklisting Interim Review
8th Jan 20132:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20138:36 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.